These certifications reflect the company's continuous commitment to maintaining international standards of environmental sustainability as well as occupational health and safety
Winlevi is authorized in EU for the treatment of acne vulgaris
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Dexlansoprazole delayed-release capsules are a proton pump inhibitor
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
Tinostamustine is an investigational drug with a potential first-in-class mechanism combining bifunctional alkylating activity and pan histone deacetylase (HDAC) inhibition
The pharma giant's 11% rise in total revenue to $43.2 billion highlights consistent execution of its growth strategy
Venus Remedies now has 29 active product approvals in Vietnam alone
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Sprycel Tablets
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
Subscribe To Our Newsletter & Stay Updated
